FBL7 Activators
FBL7 Activators are a chemical class designed to interact specifically with the F-box/LRR-repeat protein 7 (FBL7), a member of the F-box protein family. F-box proteins are critical components of the ubiquitin-proteasome system, which is a fundamental pathway for protein degradation in eukaryotic cells. They function as specificity factors that recruit substrates to the SCF (SKP1-cullin 1-F-box protein) E3 ubiquitin ligase complex, thus tagging them for ubiquitination and subsequent proteolysis by the 26S proteasome. FBL7 Activators are molecules that bind to the FBL7 protein, influencing its activity. The exact mechanisms by which these activators exert their influence can vary, but generally involve modulating the protein-protein interactions that FBL7 engages in, or altering its structural conformation, which can affect its ability to bind to its partners within the SCF complex or its target substrates.
The biochemical pathways and cellular processes that involve FBL7 are diverse, owing to the ubiquity of protein degradation mechanisms in cellular regulation. By activating FBL7, these molecules can affect a variety of cellular functions, such as cell cycle progression, signal transduction, and gene expression, among others. The specific molecular design of FBL7 Activators allows them to have high selectivity for FBL7, which is advantageous for modulating the protein's activity with precision. Research into FBL7 and its interactions with other cellular components is ongoing, and the development of FBL7 Activators is part of a broader interest in understanding the role of F-box proteins in the regulation of proteostasis and cellular function. These activators are often used as tools in experimental settings to elucidate the biological roles of FBL7 and to study the molecular details of its function within the ubiquitin-proteasome pathway.
Items 1 to 10 of 17 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA which could enhance FBL7's function if FBL7 is involved in cAMP/PKA signaling pathways. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin inhibits HMG-CoA reductase, potentially causing a compensatory upregulation of GGPS1 to maintain isoprenoid synthesis. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. If FBL7's activity is regulated by calcium-dependent pathways, ionomycin could enhance its function by enabling calcium signaling. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Similar to lovastatin, simvastatin may cause an increase in GGPS1 expression by inhibiting the upstream enzyme in the mevalonate pathway. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that mimics diacylglycerol. If FBL7 is part of a pathway downstream of PKC, PMA could enhance its activity by activating PKC signaling. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain kinases. If FBL7 is negatively regulated by a kinase that EGCG inhibits, then its activity could be enhanced by EGCG inhibition of that kinase. | ||||||
Geranylgeraniol | 24034-73-9 | sc-200858 sc-200858A | 20 mg 100 mg | $162.00 $474.00 | 14 | |
As a product of GGPS1 activity, geranylgeraniol could induce GGPS1 expression through a feedback loop mechanism. | ||||||
Farnesol | 4602-84-0 | sc-204748 sc-204748A | 50 ml 100 ml | $281.00 $374.00 | 2 | |
Farnesol serves as a precursor in the isoprenoid synthesis pathway and might induce GGPS1 expression to increase GGPP levels. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. If FBL7 is part of a signaling cascade regulated by PI3K, inhibiting PI3K could relieve negative feedback and enhance FBL7 function. | ||||||
Squalene | 111-02-4 | sc-281155 sc-281155A sc-281155B | 10 ml 100 ml 500 ml | $49.00 $92.00 $215.00 | 1 | |
Squalene, involved in cholesterol synthesis, might influence GGPS1 expression as part of the regulatory network of the mevalonate pathway. | ||||||